Cargando…

Obesity and heart failure with preserved ejection fraction (HFprEF): the whole body question

Detalles Bibliográficos
Autor principal:	eBioMedicine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667108/ https://www.ncbi.nlm.nih.gov/pubmed/37949527 http://dx.doi.org/10.1016/j.ebiom.2023.104874

Ejemplares similares

Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs
por: Chen, Yei-Tsung, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists
por: Singh, Ajmer, et al.
Publicado: (2018)

Tubulin expression and modification in heart failure with preserved ejection fraction (HFpEF)
por: Schulz, Lisa, et al.
Publicado: (2022)

Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)
por: Valero-Muñoz, María, et al.
Publicado: (2022)

Deciphering the Dilemma: Anticoagulation for Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Jyotsna, FNU, et al.
Publicado: (2023)

Impact of readmissions on octogenarians with heart failure with preserved ejection fraction: PURSUIT‐HFpEF registry
por: Nishino, Masami, et al.
Publicado: (2021)

Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction—A Specific HFpEF Phenotype
por: Elsanhoury, Ahmed, et al.
Publicado: (2021)

Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
por: Kirkman, Danielle L., et al.
Publicado: (2020)

Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
por: Dzhioeva, Olga, et al.
Publicado: (2020)

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
por: Scheffer, Mariëlle, et al.
Publicado: (2020)

Heart Failure in Patients with Preserved Ejection Fraction: Questions Concerning Clinical Progression
por: Louridas, George E., et al.
Publicado: (2016)

Diabetes Is the Strongest Predictor of Limited Exercise Capacity in Chronic Heart Failure and Preserved Ejection Fraction (HFpEF)
por: Berisha-Muharremi, Venera, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics
por: Abudureyimu, Miyesaier, et al.
Publicado: (2022)

Loeffler Endocarditis Causing Heart Failure with Preserved Ejection Fraction (HFpEF): Characteristic Images and Diagnostic Pathway
por: Lupu, Silvia, et al.
Publicado: (2022)

Epicardial Adipose Tissue and Development of Atrial Fibrillation (AFIB) and Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Zain, Sarmad, et al.
Publicado: (2023)

Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions
por: Fauchier, Laurent, et al.
Publicado: (2023)

Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF)
por: Parikh, Riya R, et al.
Publicado: (2022)

Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis
por: Jin, Xuanyi, et al.
Publicado: (2022)

Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study
por: Gatzoulis, Konstantinos A, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Predictive potential of macrophage migration inhibitory factor (MIF) in patients with heart failure with preserved ejection fraction (HFpEF)
por: Luedike, Peter, et al.
Publicado: (2018)

Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
por: Patel, Ravi B., et al.
Publicado: (2021)

Prognostic significance of dipstick proteinuria in heart failure with preserved ejection fraction: insight from the PURSUIT-HFpEF registry
por: Oeun, Bolrathanak, et al.
Publicado: (2021)

Application Value of Systemic Inflammatory Indexes in the Clinical Evaluation of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)
por: Wang, Ruxin, et al.
Publicado: (2022)

OR19-2 Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) with Low and High Dose of Triiodothyronine: an Animal Model of Metabolic Syndrome with HFpEF
por: Almeida-Coelho, João, et al.
Publicado: (2022)

Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction
por: Altara, Raffaele, et al.
Publicado: (2017)

Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity
por: Dhore-patil, Aneesh, et al.
Publicado: (2022)

Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling
por: Stencel, Jason, et al.
Publicado: (2023)

Large Animal Models of Heart Failure With Reduced Ejection Fraction (HFrEF)
por: Spannbauer, Andreas, et al.
Publicado: (2019)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Using routinely collected health record data for the earlier detection of heart failure with preserved ejection fraction: FIND-HFpEF
por: Nadarajah, Ramesh, et al.
Publicado: (2023)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Egom, Emmanuel Eroume A.
Publicado: (2021)

Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction
por: Sarma, Satyam, et al.
Publicado: (2020)

Obesity-related heart failure with preserved ejection fraction: diagnostic and therapeutic challenges
por: Jung, Mi-Hyang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p0f8ig8hvjmq9fvrnd3edf8973